Abstract:Reduction and pH dual-sensitive reversibly core-crosslinked polypeptide micelles were developed from lipoic acid (LA) and cis-1,2-cyclohexanedicarboxylic acid (CCA) decorated poly(ethylene glycol)-b-poly(L-lysine) (PEG-P(LL-CCA/LA)) block copolymers for active loading and triggered intracellular release of doxorubicin (DOX). PEG-P(LL18-CCA4/LA14) and PEG-P(LL18-CCA8/LA10) (M(n PEG) = 5.0 kg/mol) formed nano-sized micelles that were readily crosslinked in the presence of a catalytic amount of dithiothreitol (DTT) in phosphate buffer (pH 7.4, 10 mM). PEG-P(LL18-CCA4/LA14) micelles displayed an elevated DOX loading over PEG-P(LL14-LA14) controls likely due to presence of ionic interactions between DOX and CCA. These core-crosslinked polypeptide micelles while exhibiting high stability against extensive dilution and high salt concentration were quickly dissociated into unimers in the presence of 10 mM DTT. The in vitro release studies showed that DOX release from PEG-P(LL18-CCA4/LA14) micelles at pH 7.4 and 37 °C was significantly inhibited by crosslinking (i.e. less than 20% release in 24 h). The release of DOX was, however, doubled under endosomal pH of 5.0, possibly triggered by cleavage of the acid-labile amide bonds of CCA. In particular, rapid DOX release was observed under a reductive condition containing 10 mm glutathione (GSH), in which 86.0% and 96.7% of DOX were released in 24 h at pH 7.4 and 5.0, respectively, under otherwise the same conditions. MTT assays demonstrated that these core-crosslinked polypeptide micelles were practically non-toxic up to a tested concentration of 1.0 mg/mL, while DOX-loaded micelles caused pronounced cytotoxic effects to HeLa and HepG2 tumor cells with IC50 (inhibitory concentration to produce 50% cell death) of ca. 12.5 μg DOX equiv/mL following 48 h incubation. Confocal microscopy observations revealed that DOX-loaded crosslinked PEG-P(LL18-CCA4/LA14) micelles more efficiently delivered and released DOX into the nuclei of HeLa cells than PEG-P(LL14-LA14) counterparts. These dual-bioresponsive core-crosslinked polypeptide micelles have appeared as an advanced platform for targeted cancer therapy.

Preparation of multilocation reduction-sensitive core crosslinked folate-PEG-coated micelles for rapid release of doxorubicin and tariquidar to overcome drug resistance.

Preparation of pH and redox dual-sensitive core crosslinked micelles for overcoming drug resistance of DOX

Core Cross-Linked Polyphosphoester Micelles with Folate-Targeted and Acid-Cleavable Features for Ph-Triggered Drug Delivery

Reversible Core-Crosslinked Nanocarriers with Ph-Modulated Targeting and Redox-Controlled Drug Release for Overcoming Drug Resistance

Co-Delivery of Pdtc and Doxorubicin by Multifunctional Micellar Nanoparticles to Achieve Active Targeted Drug Delivery and Overcome Multidrug Resistance

Ph/reductant Dual-Responsive Core-Cross-Linked Micelles Via Facile in Situ ATRP for Tumor-Targeted Delivery of Anticancer Drug with Enhanced Anticancer Efficiency.

Folate-Conjugated Amphiphilic Block Copolymer Micelle For Targeted And Redox-Responsive Delivery Of Doxorubicin

Folate-Functionalized Polymeric Micelles For Tumor Targeted Delivery Of A Potent Multidrug-Resistance Modulator Fg020326

Reduction-responsive Disassemblable Core-Cross-linked Micelles Based on Poly(ethylene Glycol)-B-poly(n-2-hydroxypropyl Methacrylamide)-Lipoic Acid Conjugates for Triggered Intracellular Anticancer Drug Release.

Reduction-sensitive reversibly crosslinked biodegradable micelles for triggered release of doxorubicin.

Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.

Biodegradable Interlayer-Crosslinked Polymer Micelles with Reduction Sensitivity for Non-Small Cell Lung Cancer Therapy.

Facile Preparation of Core Cross-Linked Nanomicelles Based on Graft Copolymers with Ph Responsivity and Reduction Sensitivity for Doxorubicin Delivery.

Doxorubicin derivative loaded Acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells.

Reduction and Ph Dual-Sensitive Core-Crosslinked Polypeptide Micelles for Triggered Doxorubicin Release

Cyclodextrin Based Unimolecular Micelles with Targeting and Biocleavable Abilities As Chemotherapeutic Carrier to Overcome Drug Resistance.

Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells.

A simple reduction-sensitive micelles co-delivery of paclitaxel and dasatinib to overcome tumor multidrug resistance

Enhanced Effect of Ph-Sensitive Mixed Copolymer Micelles for Overcoming Multidrug Resistance of Doxorubicin.

An Improved D-α-tocopherol-based Nanocarrier for Targeted Delivery of Doxorubicin with Reversal of Multidrug Resistance.

Reduction-responsive core-shell-corona micelles based on triblock copolymers: novel synthetic strategy, characterization, and application as a tumor microenvironment-responsive drug delivery system.